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Abstract
Gestational diabetes mellitus (GDM) is an obstetric disorder affecting approximately 10% of pregnancies. The
4HFHS (High Fat High Sucrose) mouse model emulates GDM in lean women. Dams are fed a HFHS diet
one week prior to mating and throughout gestation resulting in inadequate insulin response to glucose in mid-
late pregnancy. The offspring of HFHS dams have increased adiposity, thus, we hypothesized that maternal
metabolic alterations during lean GDM would compromise ovarian function in offspring both basally and in
response to a control or HFHS diet in adulthood. Briefly, DLPL were lean dams and control diet pups; DLPH
were lean dams and HFHS pups; DHPL were HFHS dams and control diet pups and DHPH were HFHS dams
and HFHS pups. A HFHS challenge in the absence of maternal GDM (DLPL vs. DLPH) increased 3 and
decreased 30 ovarian proteins. Maternal GDM in the absence of a dietary stress (DLPL vs. DHPL) increased
abundance of 4 proteins and decreased abundance of 85 proteins in the offspring ovary. Finally, 87 proteins
increased, and 4 proteins decreased in offspring ovaries due to dietary challenge and exposure to maternal
GDM in utero (DLPL vs. DHPH). Canopy FGF signaling regulator 2 (CNPY2), Deleted in azoospermia-
associated protein 1 (DAZAP1), Septin 7 (SEPT7), and Serine/arginine rich splicing factor 2 (SRSF2) were
altered across multiple offspring groups. Together, these findings suggest a possible impact on fertility and
oocyte quality in relation to GDM exposure in utero as well as in response to a western diet in later life.
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ABSTRACT 
Gestational diabetes mellitus (GDM) is an obstetric disorder affecting approximately 10% of 
pregnancies. The 4HFHS (High Fat High Sucrose) mouse model emulates GDM in lean women. 
Dams are fed a HFHS diet one week prior to mating and throughout gestation resulting in 
inadequate insulin response to glucose in mid-late pregnancy. The offspring of HFHS dams have 
increased adiposity, thus, we hypothesized that maternal metabolic alterations during lean GDM 
would compromise ovarian function in offspring both basally and in response to a control or 
HFHS diet in adulthood.  Briefly, DLPL were lean dams and control diet pups; DLPH were lean 
dams and HFHS pups; DHPL were HFHS dams and control diet pups and DHPH were HFHS 
dams and HFHS pups.  A HFHS challenge in the absence of maternal GDM (DLPL vs. DLPH) 
increased 3 and decreased 30 ovarian proteins. Maternal GDM in the absence of a dietary stress 
(DLPL vs. DHPL) increased abundance of 4 proteins and decreased abundance of 85 proteins in 
the offspring ovary. Finally, 87 proteins increased, and 4 proteins decreased in offspring ovaries 
due to dietary challenge and exposure to maternal GDM in utero (DLPL vs. DHPH). Canopy FGF 
signaling regulator 2 (CNPY2), Deleted in azoospermia-associated protein 1 (DAZAP1), Septin 
7 (SEPT7), and Serine/arginine rich splicing factor 2 (SRSF2) were altered across multiple 
offspring groups. Together, these findings suggest a possible impact on fertility and oocyte 
quality in relation to GDM exposure in utero as well as in response to a western diet in later life.  
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INTRODUCTION 
The ovary produces the female gamete, the oocyte, and primary sex hormones 17-
estradiol (E2) and progesterone (P4).  Oocytes arise from primordial germ cells in utero and 
remain encased in primitive follicular structures, arrested at the diplotene stage of meiosis, or 
they degenerate through programmed cell death termed atresia [1].  Through the natural 
progression of time or due to factors that may expedite the process, the pool of ovarian oocytes 
ultimately becomes depleted and ovarian senescence occurs in women [1].  Ovarian failure 
preceding age 40 is characterized as primary ovarian insufficiency (POI) [2], which may be 
attributable to genetics, autoimmune disorders, iatrogenesis, surgical, or unknown etiology, and 
affects approximately 1% of women [3].   
In recent years, globally there has been an expeditious rise in obesity rates in both adults 
and children, predisposing them for health problems including diabetes [4], cardiovascular 
disease [5], cancer [6], and reproductive decline [7].  In the overweight or obese female, 
reproductive complications include POI [8], polycystic ovary syndrome (PCOS) [9], poor oocyte 
quality [10], decreased fecundity [11], gestational diabetes mellitus (GDM) [12], and offspring 
congenital abnormalities [13].  Changes in central metabolism negatively affect the ovary, with 
insulin responsive pathways such as the phosphatidylinositol 3-kinase (PI3K) pathway being 
upregulated during obesity [14], reduced follicle number [15], altered steroid hormone 
biosynthesis [16], and inflammation [15].  Additionally, basal ovarian DNA damage and a 
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blunted ovarian response to genotoxicants occurs in obese mice [16-19].  Offspring exposed to 
maternal obesity have increased risk of neural tube defects [20], glucose intolerance [21], altered 
neurobehavior [22], intrauterine growth restriction (IUGR) [23], and increased circulating 
cholesterol and body fat [24].  The reproductive outcomes on female offspring exposed to 
maternal obesity in utero include a decrease in the ovarian follicular reserve [25, 26], decreases 
in ovarian vascularity [27], and disturbances in the estrous cycle in a rodent model [28].  
In association to the rise of obesity in reproductive age women, the prevalence of GDM is 
also increasing.  Defined as glucose intolerance during pregnancy, GDM may affect up to 20% 
of pregnancies, dependent on population demographics [29], screening and diagnostic criteria 
[29], and pre-gestational maternal lifestyle factors [30].  Insulin sensitivity naturally decreases 
during pregnancy for all women [31] but overweight and obese women have higher risk of 
developing GDM than their lean counterparts [12, 32] and lean women with GDM have reduced 
or delayed first-phase insulin response to glucose [31]. Immediate health concerns are posed by 
GDM, and although GDM normally resolves postpartum, long-term maternal health effects 
include a 60% higher risk of acquiring Type 2 diabetes [33, 34].  Fetal and neonatal 
complications include macrosomia [35], hypoglycemia [36], respiratory distress [36], future 
obesity [37], and predisposition for Type 2 diabetes [38].  
When considering our recent findings that progressive obesity alters a variety of ovarian 
intracellular signaling pathways that could compromise fertility and offspring health [14, 15, 17, 
19, 39, 40], we hypothesized that similar alterations would result from exposure of the 
developing ovary to metabolic alterations in utero.  A lean GDM model has been developed 
using acute, high-fat feeding one week prior to conception and throughout gestation, thereby 
separating effects of pre-conceptional obesity from maternal gestational metabolic alterations on 
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the offspring [41]. We utilized ovaries from offspring who experienced GDM in utero and also 
assessed whether a dietary stress in adulthood would affect the ovarian response to such an 
insult.   
 
MATERIALS AND METHODS 
Animal Procedures and Tissue Collection 
Ovarian tissue utilized in this study was obtained as part of a larger study [42].  Briefly, 
gestational diabetes was induced in female C57B16/J mice (n = 14) by feeding a high fat, high 
sucrose (HFHS; 45% kcal/fat (lard and soybean oil) and 17% kcal/sucrose) diet (D12451, 
Research Diets, Inc) one week prior to mating and for the duration of gestation, for a total of 4 
weeks as described [41, 42].  Control female C57B16/J mice (Jackson Laboratories; n = 20) were 
fed a chow breeder diet (17% kcal/fat (lard) and 2.4% kcal/sucrose; LabDiet 5008, Purina) 
throughout the duration of the study.  Both groups of females were mated to C57B16/J sires.  
Female offspring from each litter (control – n = 30; GDM – n = 16) were maintained on the 
chow breeder diet, until 23 weeks of age, at which point 1-2 females from each litter was fed the 
HFHS diet until 31 weeks of age, at which time both groups of offspring were humanely 
sacrificed.  Mice were not at the same stage of the estrous cycle at euthanasia.   Ovaries were 
collected from adult females and one ovary was snap-frozen in liquid nitrogen before storage at -
80°C. The contralateral ovary was fixed in 4% paraformaldehyde and stored in 70% ethanol 
prior to histological processing.  Ovaries utilized for frozen tissue sections were collected from 
10-week-old female C57B16/J mice during the pro-estrus stage of the estrous cycle and fixed in 
4% paraformaldehyde overnight at 4C.  For cryoprotection, fixed ovaries were passed in 10% 
sucrose/PBS solution for 1-3 hours at room temperature followed by 30% sucrose/PBS solution 
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at 4C overnight prior to embedding in OCT medium (Fisher Healthcare).  All animal procedures 
were approved by the University of Missouri or the Iowa State University Institutional Animal 
Care and Use Committee and handled according to National Institutes of Health Guide for Care 
and Use of Laboratory Animals.   
 
Histology and Follicle Counting 
Fixed ovaries were paraffin embedded and serially sectioned (n = 4/treatment) at 5 µm, 
with every 6
th
 section mounted onto glass slides and stained with hematoxylin and eosin.  
Healthy follicles containing oocytes with a distinct oocyte nucleus were counted and classified as 
follows:  primordial follicles were identified by an oocyte surrounded by a single layer of 
squamous granulosa cells; primary follicles contained the oocyte surrounded by a single layer of 
cuboidal granulosa cells, and secondary follicles contained an oocyte surrounded by multiple 
layers of granulosa cells.  Slide identity was blinded to prevent counting bias. Follicle counts 
performed on a Nikon Optiphot using a 5x or 20x objective and bright field images captured 
on an inverted DMI3000B microscope (Leica) and QICAM MicroPublisher 5.0 (MP5.0-RTV-
CLR-10, QIMAGING) camera using QCapture software at a 5x objective. Total follicles counted 
per ovary were compared between treatments.  
 
Protein Isolation, LC-MS/MS, and Proteome Analysis 
Total ovarian protein was isolated (n = 3/treatment) in lysis buffer (50 mM Tris-HCL, 1 
mM EDTA, pH 8.5), homogenized, and centrifuged at 10,000 rpm at 4C for 15 min.  
Supernatant was collected, and protein content was quantified using bicinchoninic acid assay 
(BCA; Pierce BCA Protein Assay Kit, Thermofisher). A working protein dilution of 50 g/l 
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was prepared with lysis buffer.  For LC-MS/MS analysis, total protein (50 µg/l) was digested 
with trypsin/Lys-C for 16 hours, dried down and reconstituted in buffer A (47.5l; 0.1% formic 
acid/water) and Peptide Retention Time Calibration (PRTC) mixture was utilized as a standard 
(25 fmol/µl) and was spiked into each sample to serve as an internal control.  Protein (10 µg) and 
PRTC (250 fmol) were injected onto a liquid chromatography column (Agilent Zorbax SB-C18, 
0.5mm x 150mm, 5 micron) using an Agilent 1260 Infinity Capillary Pump.  Peptides were 
separated by liquid chromatography and analyzed using a Q Exactive
TM
 Hybrid Quadrupole-
Orbitrap Mass Spectrometer with a higher energy collisional dissociation (HCD) fragmentation 
cell. The resulting intact and fragmentation pattern was compared to a theoretical fragmentation 
pattern (from either MASCOT or Sequest HT) to identify peptides. The relative abundance of the 
identified proteins was based on the areas of the top three unique peptides for each sample.  The 
arithmetic mean of the PRTC was used as normalization factor.  For each peptide, the signal 
intensity was divided by the arithmetic mean of the PRTC before further analysis.  
Metaboanalyst 3.0 [43, 44] was used for data analysis. Upon finding data integrity to be 
satisfactory (no peptide with more than 50% missing replicates, positive values for the area), 
missing value imputation was performed using a Singular Value Decomposition (SVD) method. 
Filtering, based on interquartile range, was performed to remove values unlikely to be of use 
when modeling the data, followed by generalized log transformation (glog 2) before data 
analysis. The control and treatment samples were compared by the Student's t-test. Differences 
between groups were assessed by the Mann-Whitney rank sum test. All p-values were two sided. 
To adjust for multiple comparisons, Bonferroni correction was applied and only p-values less 
than 0.1 were considered as statistically significant. The principal component analysis (PCA) 
analysis was performed using the prcomp package and pairwise score plots providing an 
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overview of the various separation patterns among the most significant components were 
accessed. The partial least squares (PLS) regression was then performed using the plsr function 
provided by R pls package. The classification and cross-validation were also performed using the 
caret package. The UniProt protein identifiers that were up/down regulated were used to retrieve 
the corresponding KEGG identifiers using the “Retrieve/ID mapping” tool of UniProt (accessible 
at tp://www.uniprot.org/uploadlists/). KEGG identifiers were then used to retrieve biological 
pathway association of the proteins. 
 
Gene Ontology Analysis  
Gene Ontology (GO) analysis was performed using PANTHER version 14.1 
(http://www.pantherdb.org).  Proteins identified in the control and experimental samples were 
compared to the Mus musculus reference list for a statistical overrepresentation test to highlight 
categories in biological process, molecular function, and cellular components with significant 
fold-enrichment in our samples.  The Fisher’s Exact test with False Discovery Rate (FDR) 
correction was used with P < 0.05 considered as a statistically significant difference.   
 
Immunofluorescence staining 
Slides were deparaffinized in Citrisolv and rehydrated in subsequent washes of ethanol 
(100%, 95%, 75%), followed by one wash in ddH2O.  Heat mediated antigen retrieval was 
performed using citrate buffer (10 mM citric acid, 0.5% Tween20, pH 6.0) in a microwave for 22 
min.  Tissue sections on histology slides were encircled with a histology pap pen to keep liquid 
concentrated on the tissue during processing, followed by the application of blocking solution 
(0.1M PBS/0.4% BSA/0.2% Tween20/2.5% goat serum) to the slides for 1 hour at room 
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temperature.  In addition, frozen tissue from 10-week-old female C57B16/J mice was utilized to 
determine localization of canopy FGF signaling regulator 2 (CNPY2), deleted in azoospermia-
associated protein 1 (DAZAP1), pre-mRNA serine/arginine rich splicing factor 2 (SRSF2), and 
septin 7 (SEPT7).  Briefly, frozen slides were thawed on a 37C slide warmer for 5 minutes, 
tissue encircled with a histology pap pen, and rehydrated in phosphate buffered saline with 0.1% 
Tween20 (PBSTw) for 20 minutes at room temperature before addition of blocking solution 
(described above).  Primary antibodies for CNPY2, DAZAP1, SRSF2, SEPT7, phosphorylated 
histone 2AX (γH2AX), and cleaved caspase-3 (CASP3; dilutions listed in Supplementary 
Table 1) were added into fresh blocking solution, applied to tissue sections and allowed to 
incubate in a humidified box at 4°C overnight.  Slides were washed (3 x 10 min) in PBSTw.  
Secondary antibodies (Supplementary Table 1) were added into fresh blocking solution and 
incubated at room temperature for 60 min, followed by washes (3 x 10 min) in PBSTw.  Slides 
were allowed to air dry, counterstained and mounted with 4-6-diamidino-2-phenyllindole (DAPI) 
and stored at 4°C until image capture.  Negative technical controls to confirm specificity were 
performed using secondary antibodies alone (Supplementary Figure 4). Images were captured 
on a Zeiss LSM700 confocal microscope equipped with an AxioCam MRc5 using a 20x 
objective lens. For γH2AX (n = 4 ovaries per treatment;  3 sections per ovary; sections selected 
randomly) and cleaved CASP3 (n = 4 ovaries per treatment;  3 sections per ovary; sections 
selected randomly), immunopositive cells were manually counted in the granulosa cells and/or 
oocytes of primary, secondary and antral follicles using the cell counter module of ImageJ 
(https://imagej.nih.gov/ij/plugins/cell-counter.html).   
 
Statistical Analysis  
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Statistical analyses were performed using GraphPad Prism 7.0 One-way ANOVA 
function with multiple comparisons.  Each treatment mean value was compared to the control 
(DLPL) mean value using Dunnett’s correction with significance level set at P  0.05.    
 
RESULTS  
GDM exposure in utero and subsequent dietary challenge decreased healthy follicle number 
The impact of GDM exposure in utero and/or dietary stressor later in life on healthy 
follicle numbers was determined (Figure 1).  There was no difference in primordial follicle 
number between treatment groups (DLPH; DHPL; and DHPH) relative to DLPL control (P = 0.1361; 
Figure 1.A). Dietary stress in adulthood in the DLPH mice did not impact primordial, primary, or 
secondary follicle number (Figure 1A-C). GDM exposure in utero also did not affect primordial, 
primary or secondary follicle number (Figure 1A-C). The combination of GDM in utero with 
dietary stress in adulthood in the DHPH mice numerically reduced primordial follicle number 
(Figure 1A) and decreased (P < 0.05) the number of primary and secondary follicles (Figure 1 
B,C).    
 
Impact of in utero exposure to GDM on DNA damage in the ovary 
To determine if offspring from GDM mothers had increased ovarian DNA damage, tissue 
sections were immunologically stained for H2AX and positive foci were quantified.  The 
number of ovarian cells (granulosa cells and/or oocytes) that contained positive H2AX foci in 
the primary, secondary, or antral follicles were not different between treatment groups (DLPL: 
30.1 ± 13.5; DLPH: 5.5 ± 3.6; DHPL: 48.3 ± 20.5; DHPH: 9.8 ± 5.7; Figure 2 A-F). 
 
D
ow
nloaded from
 https://academ
ic.oup.com
/biolreprod/advance-article-abstract/doi/10.1093/biolre/ioz116/5530419 by Iow
a State U
niversity user on 17 July 2019
 11 
Impact of in utero exposure to GDM on apoptosis in the ovary 
In order to assess levels of apoptosis in the ovary, immunofluorescence staining was 
performed to quantify the level of cleaved CASP3.  There was no impact of GDM exposure in 
utero or dietary stress on any treatment group in the level of cleaved CASP3 that was detected in 
the granulosa cells or oocytes of primary, secondary, or antral follicles (DLPL: 8.8 ± 2.1; DLPH: 
12 ± 2.2; DHPL: 10.3 ± 3; DHPH: 13 ± 7.6; Figure 3 A-F).    
 
In utero exposure to lean GDM alters the offspring ovarian proteome  
There were 504 ovarian proteins identified in DHPL offspring who experienced GDM in 
utero but did not receive the high fat diet in adulthood.  Relative to DLPL offspring ovaries, 85 
proteins were reduced and 4 were increased in abundance in the ovaries of DHPL mice 
(log2foldchange  1 and P-value  0.1; Figure 4A; Supplementary Table 2).   
 
A high fat diet affects the ovarian proteome in adult mice 
A total of 470 ovarian proteins were identified in the DLPH mice.  Relative to the Relative 
to DLPL offspring ovaries, 30 proteins were decreased, and 3 proteins were increased in the 
ovaries of DLPH (log2foldchange  1 and P-value  0.1; Figure 4B; Supplementary Table 3).   
 
Additive effect of dietary stress in later life on the proteome of offspring exposed to lean GDM 
in utero  
In the DHPH ovaries, 481 total proteins were identified.  When compared to the DLPL 
mice, 4 proteins were increased and 87 proteins were decreased, indicating the combined effects 
of GDM exposure in utero with an HFD stress in adulthood (log2foldchange  1 and P-value  
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0.1; Figure 4C; Supplementary Table 4). Furthermore, comparison of the ovarian proteome of 
the DHPH with the DLPH mice revealed the additive effects of in utero GDM since both of these 
groups experienced the dietary stressor in adulthood and 5 proteins were increased and 3 proteins 
were decreased (log2foldchange  1 and P-value  0.1; Supplementary Table 5). 
Of these differentially expressed proteins, 8, 49, and 52 proteins were identified that were 
unique to DLPH, DHPL, and DHPH, respectively.  In addition, 20 proteins were shared between the 
groups exposed to GDM in utero, 5 proteins are shared between the groups exposed to the HFD, 
and 14 proteins were shared between all the treatment groups (Figure 5).   
 
Over represented gene ontology (GO) analysis of maternal GDM exposure in the absence or 
presence of dietary stress in adulthood 
Proteins identified as being different from the DLPL mice (log2foldchange  1 and P-
value  0.1) in each treatment group (DLPH – n = 33; DHPL – n = 89; and DHPH – n = 91) were 
assigned to biological process, molecular function, and cellular component using PANTHER GO 
analysis (Fischer’s Exact with FDR multiple test correction; P < 0.05).  For biological process, 
several of the GO categories that showed substantial enrichment in the DHPH ovaries relative to 
controls were associated with a catabolic or metabolic process (Supplementary Figure 1A).  
There was a 43-fold enrichment of proteins in the DHPH ovaries involved in the hydrogen 
peroxide catabolic process, including the proteins catalase (CAT), apolipoprotein A-IV 
(APOA4), and peroxiredoxin-5, mitochondrial (PRDX5).  Proteins from DHPL were enriched in 
categories related to protein complex disassembly, depolymerization, and regulation of actin 
filament activity (Supplementary Figure 1B).  Actin crosslink formation had the highest fold-
enrichment in the GDM only offspring, with proteins such as Filamin-A (FLNA) and 
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myristoylated alanine-rich C-kinase substrate (MARCKS) included in the cluster.  There were no 
significant categories assigned in the HFHS diet alone offspring.   
Concerning molecular function, proteins from GDM-exposed and HFHS-fed offspring 
(DHPH) ovaries, GO categories that were enriched mainly involved enzymatic activity or binding 
(Supplementary Figure 2A).  Transaminase activity included protein-glutamine gamma 
glutamyltransferase 2 (TGM2) and aspartate aminotransferase, mitochondrial (GOT2).  Ovaries 
from females exposed to GDM in utero without a HFHS challenge (DHPL), had more binding 
categories assigned, with the protein kinase C binding category having a 20-fold enrichment 
(Supplementary Figure 2B).  Proteins identified in this category included serine/arginine-rich 
splicing factor 2 (SRSF2), FLNA, and MARCKS.  Similar to the GDM only group (DHPL), the 
HFHS only group (DLPH) had all identified GO terms associated with binding (Supplementary 
Figure 2C).  Pre-mRNA binding was enriched 61-fold in this group, with SRSF2, 
polypyrimidine tract-binding protein (PTBP1), and the splicing factor U2AF 65 kda subunit 
(U2AF2) protein identified in this cluster. 
GO terms assigned to cellular component included those involved in cell junctions and 
various cell complexes.  Fascia adherens was enriched 56-fold in the DHPH ovaries, with proteins 
such as vinculin (VCL), alpha-actinin-1 (ACTN1), and spectrin alpha chain, non-erythrocytic 1 
(SPTAN1) identified (Supplementary Figure 3A).  The interchromatin granule cluster was 
enriched greater than 100-fold, including the proteins SRSF2 and cleavage and polyadenylation 
specificity factor subunit 6 (CPSF6) (Supplementary Figure 3B).  There were substantially less 
categories identified in the DLPH group.  The cytoplasm cluster had the highest enrichment only 
being enriched by 1.75-fold, containing proteins such as SRSF2, PTBP1, and tubulin-specific 
chaperone A (TBCA). 
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Ovarian localization of CNPY2, DAZAP1, SRSF2 and SEPT7 
In order to establish the ovarian localization of selected proteins identified to be of 
interest from the LC-MS/MS analysis, but for whom the ovarian location is unknown, 
immunofluorescence staining was performed on ovarian sections from adult C57B16/J mice.  
From the LC-MS/MS analysis, CNPY2 had a log2fc of -1.65, -1.72, and -2.18 in groups DLPH, 
DHPL, and DHPH, respectively.  Positive immunofluorescence staining for the CNPY2 protein 
was observed in the theca and granulosa cells, and the pericytoplasmic region of the oocyte in 
primary, secondary, and antral follicle stages (Figure 6A).   
DAZAP1 had a -2.43 log2fc and -5.13 log2fc in the DHPL and DHPH groups, respectively, 
in the LC-MS/MS analysis, but was not altered in the DLPH ovaries, suggesting an impact of 
GDM exposure in utero, and further amplification by dietary stress on ovarian DAZAP1 
abundance.  Immunological staining for DAZAP1 demonstrated positive staining in luteal cells, 
but not in any other follicular structure or in the oocyte (Figure 6B).   
In contrast to the previous proteins selected from our data set, SRSF2 was identified by 
LC-MS/MS analysis as being increased in groups DLPH, DHPL, and DHPH with log2fc of 1.70, 
1.91, and 1.42, respectively, relative to the DLPL ovaries.  SRSF2 protein was determined by 
immunofluorescence staining to be localized to the oocyte peri-cytoplasmic region and nucleus 
in pre-ovulatory follicles (Figure 6C). 
SEPT7 was noted from the LC-MS/MS analysis to be decreased in the DLPH, DHPL, and 
DHPH ovaries by -1.04, -1.43, and -1.07 log2fc, respectively.  Positive immunofluorescence 
staining for SEPT7 was observed in the oocyte, granulosa, and theca cells of primary, secondary, 
and antral follicles (Figure 6D).  
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DISCUSSION 
The reproductive phenotypic impacts of obesity and insulin resistance have been well 
characterized, yet the percentage of the population at risk continues to increase [45].  In parallel 
with rising obesity rates, the number of women acquiring GDM is also increasing [46].  One of 
the major risk factors for GDM development is pre-gestational obesity and/or insulin resistance, 
although interestingly around a third of cases occur in lean women [47].   
While the underlying etiology of GDM remains unknown, several experimental animal 
models have been developed that effectively mimic the most common GDM features.  Partial 
pancreatectomy in post-pubertal rodents results in a mild type 1 diabetes phenotype via the 
reduction of -cell numbers, but limitations include the latency for diabetic symptoms to appear  
[48].  Administration of alloxan and streptozotocin (STZ) impairs and destroys pancreatic -
cells, leading to hyperglycemia and insulin insufficiency [49-51].  Nicotinamide (NA) injection 
prior to STZ administration protects the pancreas from severe damage and leads to a lower 
number of fetal malformations [52-54].  Mouse models of GDM are also available via gene 
knockout or transgenic overexpression but although effective at emulating GDM, many of these 
genetic models have more severe phenotypes than typically observed in human cases of GDM 
and the genetic changes may be passed on to offspring.  A commonly used GDM mouse model 
are females who are heterozygous for a mutation in the leptin receptor (ObR; Db
-/+
), who have 
reduced glucose homeostasis in the non-pregnant state, but spontaneously develop hyperphagic 
feeding, increased adiposity, insulin resistance, and glucose intolerance during pregnancy [55], 
although conflicting results have been noted in other studies [56-58].   
Another approach for inducing GDM is via dietary manipulation.  Dams consuming a 
high-fat diet to induce obesity and insulin resistance pre-pregnancy have a GDM phenotype 
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during pregnancy [59-63].  The maternal model utilized in our study is also diet-induced, and 
includes a high fat and high sugar diet, which is comparable to the diet of the human population, 
but obesity is absent prior to gestation.  With this method, we are able to elucidate the 
mechanisms behind GDM without the additive effects of obesity.  These females exhibit 
susceptibility to glucose intolerance later in life when challenged with the same diet but in the 
absence of increased body mass [41]. An obvious drawback with using this model is that there is 
a confounding effect of differing dietary composition and the HFHS mice in this study received 
an additional fat source to the controls in the form of sunflower oil. Future studies aimed at 
assessing any additive impacts of differing fat source on the ovarian endpoints measured are 
possible in the future, though it is far more plausible that it is the increased adiposity in this 
model that contributes to the ovarian effects reported herein.  
 The ramifications of GDM and the health of the offspring also need consideration.  In 
addition to risk of stillbirth, babies born to mothers who experience diabetes during pregnancy 
have higher rates of macrosomia [35], hypoglycemia [36], respiratory distress [36], future 
obesity [37], and like the mother, a predisposition for type 2 diabetes later in life [38].  Offspring 
that were exposed to our model of GDM in utero and later on challenged with the HFHS diet had 
increased body weight, higher body fat percentage, and increased adipose insulin sensitivity [42].  
Reproductive effects on the male offspring from these dams included reduced sperm counts, 
reduced germ cell apoptosis, and low testosterone [64].  Our results in the female offspring 
corroborate the reproductive effects noted in the males, with reduced numbers of healthy primary 
and secondary follicle numbers, as well as a numerical decrease in primordial follicle numbers in 
the DHPH mice illustrating that in utero environment coupled with a later stressor in adulthood 
may have negative impacts on female fertility.   
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Previous work from our group and others has demonstrated how the metabolic changes 
that occur during obesity can alter folliculogenesis and the responsive pathways [15, 16, 19, 65-
67].  The ovarian PI3K-PTEN-AKT-FOXO3 signaling pathway is involved in follicular 
activation via an insulin-mediated process [68, 69].  Hyperinsulinemia is common during 
obesity, and from this we have previously reported changes in the activation of the PI3K 
pathway, resulting in increased follicular activation [14].  Thus, it is possible that the observed 
lower number of follicles in the GDM offspring, especially those challenged with the high fat 
diet later in life, result from the increased body mass and insulin resistance following in utero 
metabolic exposures.  In this study, the female mice had increased adiposity as measured by 
nuclear magnetic resonance imaging as early as 4 weeks of age, despite not being introduced to 
the HFHS diet until 23 weeks of age [42].  A subject for future analysis would be to define at 
what rate the introduction of the HFHS diet to GDM offspring diminishes the follicular pool 
subsequent to GDM exposure alone.   
Obesity is also associated with ovarian DNA damage [17, 18, 40] and throughout the 
body [70].  Interestingly, we did not observe any consequential changes on GDM and/or dietary 
stress in later life in the abundance of H2AX, which is considered the gold standard for DNA 
double strand break localization [71].  As with increased DNA damage detected in obesity, 
increased granulosa cell apoptosis has also been reported [72].  We did not, however, observe 
increased granulosa cell apoptosis as detected by cleaved CASP3 protein in our offspring 
ovaries.  The lack of additional DNA damage and cellular apoptosis in our model could be 
interpreted as that while they have increased body weight and insulin sensitivity, they have not 
necessarily amassed a metabolic syndrome severe enough to trigger a genotoxic response.  This 
remains to be determined.   
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Proteomic profiling can be highly informative in investigating alterations to proteins due 
to a defined environmental and pathological treatment.  In an unbiased proteomic approach, we 
identified several proteins of interest, including DAZAP1, SEPT7, CNPY2, and SRSF2, to be 
altered by GDM, adult dietary stress, or both.  DAZAP1 was substantially decreased in ovaries 
from female mice exposed to GDM in utero, and further impacted by the additional insult of the 
HFHS diet.  The deleted in azoospermia (DAZ) family of proteins are present in male and female 
germ cells and play a major role in germ cell development and fertility [73].  Mutations in 
DAZAP1 results in perinatal lethality, with those surviving experiencing reproductive defects 
such as sterility as well as growth retardation [74].  Fertility defects associated with DAZAP1 
have been typically described in males [75, 76], so our finding of alterations to DAZAP1 due to 
in utero GDM and dietary stress and localization in granulosa and luteal cells as well as in the 
oocyte implies that DAZAP1 may have important roles in ovarian physiology and female 
fertility through altering follicle growth and survival, potentially contributing to POI. 
The Septin family of proteins have been well characterized as being involved in the 
spindle positioning and cell division [77-79].  Loss of SEPT7 results in improper spindle 
organization in the oocyte and disruption of chromosome alignment affecting progression of 
meiosis [61].  Poor oocyte quality is attributed with increased body mass [10], and the modest 
decrease in SEPT7 observed in our study suggests that the metabolic stress from a HFHS diet, 
GDM exposure in utero, or both, may affect oocyte quality and/or maturation.  SEPT7 was also 
identified in our enriched cellular component GO analysis in both the GDM exposed groups as 
septin complex, septin ring, and septin cytoskeleton.  In agreement with this possibility, 
localization of SEPT7 within the follicle and the oocyte, further implicate SEPT7 as an essential 
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player in murine oocyte meiotic maturation, and that SEPT7 is vulnerable to alteration due to 
metabolic alterations.   
CNPY2 is pivotal in the induction of the PERK-CHOP unfolded protein response (UPR) 
response pathway, which is a highly conserved quality control mechanism for cells that are under 
endoplasmic reticulum (ER) stress [80].  The luminal chaperone GRP78 dissociates from PERK 
and CNPY2 during ER stress and unfolded protein accumulation, facilitating the initiation of the 
UPR response [80].  Furthermore, Cnpy2 is differentially expressed in human placental tissue 
from GDM pregnancies, though these results revealed a positive fold change [81] in contrast 
with our findings of decreased CNPY2 protein abundance.  We also determined the localization 
of CNPY2, with positive immunoreactivity in the theca cells, granulosa cells, and in the peri-
cytoplasm of the oocyte.     
Also associated with the cellular stress response is SRSF2, which is increased during 
genotoxic stress [82] and is increased across all treatment groups in our study and was also 
assigned to several of the GO categories that were highly enriched.  SRSF2 is an alternative 
splicing factor involved in the regulation of apoptotic caspases, with the mechanism for pro-
apoptotic or anti-apoptotic caspases determined by the numerous splice variants [83].  
Immunohistochemical analysis of SRSF2 revealed expression in the peri-cytoplasm of the 
oocyte, though analysis of cleaved CASP3 revealed no differences in the levels of apoptotic cells 
between any of the groups, so increased SRSF2 observed in this study may not be substantial 
enough to generate a pro-apoptotic response via CASP3.  Conversely, SRSF2 may be 
functioning in an anti-apoptotic response to the metabolic conditions arising from increasing 
adiposity and/or insulin resistance.    
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In conclusion, these study findings indicate the impact of GDM and HFHS diets on 
follicle number and the ovarian proteome and illustrates that GDM sensitizes the offspring ovary 
to a dietary HFHS stress later in life, consequentially impacting the number of healthy follicles.  
Further, the altered abundance of ovarian proteins in offspring exposed to maternal GDM 
emphasizes the potential long-term effects of metabolic alterations in utero on ovarian function 
in the absence of obesity.  Many of the proteins identified are those for which we have little 
understanding of their ovarian function and lay the foundation for future studies to determine 
their ovarian importance. Taken together, these findings illustrate a possible impact on fertility 
and oocyte quality provided in a two-hit stress model relative to GDM exposure in utero and in 
response to a western diet later in life and support a developmental origin of ovarian disorder 
(DOOD). 
 
Figure Legends: 
Figure 1: Effect of GDM and/or HFHS diet on ovarian follicle number.  Follicles were 
classified as (A) primordial; (B) primary; (C) secondary and counted. Bars represent mean 
counted follicle number  SEM.  Significant difference from DLPL control is indicated by the * 
symbol at = P < 0.05. Representative hematoxylin and eosin stained ovarian sections from (D) 
DLPL; (E) DLPH; (F) DHPL; and (G) DHPH are presented; scale bar = 200 m. 
 
Figure 2: Effect of GDM and/or dietary stress on ovarian γH2AX. A primary antibody 
directed against γH2AX was used to determine ovarian localization in (A) DLPL; (B) DHPL; (C) 
DLPH; (D) DHPH mice. (E) Secondary antibody only control. Red punctate staining indicates 
γH2AX while cellular DNA is stained in blue; scale bar = 50 m.  Arrows indicate γH2AX 
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positive staining in the granulosa cells of secondary follicles.  (F) The bars represent mean 
number of positive γH2AX foci  SEM; n = 4 ovaries per treatment; 3 sections per ovary. 
 
Figure 3: Effect of GDM and/or dietary stress on ovarian cleaved CASP3. A primary 
antibody directed against cleaved CASP3 was used to determine ovarian localization in (A) 
DLPL; (B) DHPL; (C) DLPH; (D) DHPH mice.  (E) Secondary antibody only control. Green staining 
indicates cleaved CASP3 while cellular DNA is stained in blue; scale bar = 50m. Arrows 
indicate cleaved CASP3 positive staining in the granulosa cells of secondary follicles.  (F) The 
bars represent mean number of positive CASP3 foci  SEM; n = 4 ovaries per treatment; 3 
sections per ovary. 
 
Figure 4: Volcano plots indicating the proteins detected by LC-MS/MS analysis and 
differing from the DLPL group. (A) DLPH; (B) DHPL; and (C) DHPH.  The dotted horizontal line 
shows where P = 0.1, with points above the line having P < 0.1 and points below having P > 0.1.  
The dotted vertical lines indicate a log2fold change of <  1.0.  Pink dots indicate proteins 
identified that are increased or decreased relative to DLPL ovaries, gray dots indicate proteins that 
did not meet selected thresholds.   
 
Figure 5: Proteins that are in common or unique between treatments. The Venn diagram 
presents the number of ovarian proteins identified as being unique to treatment or altered in 
common by treatment, relative to the DLPL group.  The number in grey circle indicates the 
number of proteins identified in the DLPH group as being different from the DLPL group; the blue 
circle indicates the number of proteins identified in the DHPL group as being different from the 
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DLPL group; and the pink circle indicates the number of proteins in the DHPH group that differ 
from the DLPL group. Overlapping areas of the circles illustrate the number of proteins that were 
altered relative to the DLPL group by two or more groups.    
 
Figure 6: Localization of ovarian proteins by immunofluorescence staining. (A) CNPY2 
(20x -1x zoom); (B) DAZAP1(20x -1x zoom); (C) SRSF2 (20x -1x zoom); and (D) SEPT7 (20x 
- 0.5x zoom) protein were localized in the adult mouse ovary. Green staining indicates the 
protein of interest while cellular DNA is stained in blue.  Solid arrow indicates theca cells; 
double tailed arrow indicates granulosa cells; dotted tail arrow indicates the peri-cytoplasm 
region of the oocyte; star indicates oocyte; scale bar = 50 m.  
 
Supplementary Figure Legends: 
 
Supplementary Table 1: Primary and secondary antibodies used. 
 
Supplementary Table 2: Ovarian proteins identified by LC-MS/MS to differ in DHPL offspring 
relative to the DLPL mice (log2foldchange  1 and P-value  0.1).   
 
Supplementary Table 3: Ovarian proteins identified by LC-MS/MS to differ in DLPH offspring 
relative to the DLPL mice (log2foldchange  1 and P-value  0.1).   
 
Supplementary Table 4: Ovarian proteins identified by LC-MS/MS to differ in DHPH offspring 
relative to the DLPL mice (log2foldchange  1 and P-value  0.1; DHPH).   
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Supplementary Table 5: Ovarian proteins identified by LC-MS/MS to differ between DLPH and 
DHPH (log2foldchange  1 and P-value  0.1).    
 
Supplementary Figure 1: Gene Ontology (GO) analysis of proteins identified as over-
represented in each treatment group when compared to the DLPL group (P < 0.05). Functional 
classification based on Biological Process in (A) DHPH and (B) DHPL. 
 
Supplementary Figure 2: Gene Ontology (GO) analysis of proteins identified as over-
represented in each treatment group when compared to the DLPL group (P < 0.05). Functional 
classification based on Molecular Function in (A) DHPH; (B) DHPL; and (C) DLPH.  
 
Supplementary Figure 3: Gene Ontology (GO) analysis of proteins identified as over-
represented in each treatment group when compared to the DLPL group (P < 0.05). Functional 
classification based on Cellular Component in (A) DHPH and (B) DHPL.  
 
Supplementary Figure 4: Technical control for immunofluorescence staining. Ovaries from an 
adult mouse were immunologically stained using only the secondary antibody appropriate for 
(A) CNPY2; (B) DAZAP1; (C) SRSF2; and (D) SEPT7; scale bar = 50 m.    
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Supplementary Figure 4: Technical control for immunofluorescence staining. Ovaries from an 156 
adult mouse were immunologically stained using only the secondary antibody appropriate for (A) 157 
CNPY2; (B) DAZAP1; (C) SRSF2; and (D) SEPT7; scale bar = 50 µm.    158 
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Supplementary Table 1: Primary and secondary antibodies used in this study. 12 
 13 
  14 
Primary Antibody Host  Dilution  Supplier  Code 
DAZAP1 Rabbit 1:100 (F) Thermo Fisher PA5-52083 
CNPY2 Rabbit 1:100 (F) Thermo Fisher PA5-46131 
SEPT7 Rabbit 1:100 (F) Abcam Ab211482 
SRSF2 (SC35) Rabbit 1:100 (F) Thermo Fisher PA5-78164 
H2AX Rabbit 1:50 (P) Cell Signaling 2577 
Cleaved caspase 3 Rabbit 1:100 (P) Cell Signaling  9661 
Secondary Antibody Host  Dilution  Supplier  Code 
Rabbit IgG 488 
Rabbit IgG 568 
Goat  
Goat 
1:500 
1:500 
Thermo Fisher 
Thermo FIsher 
A11008 
A11011 
Supplementary Table 2 15 
 16 
UniProtID Protein names log2(FC) p value 
Q8BTI8 Serine/arginine repetitive matrix protein 2 -3.828 0.054 
P14602 Heat shock protein beta-1 -2.897 0.003 
Q3TW96 
UDP-N-acetylhexosamine pyrophosphorylase-like 
protein 1 -2.822 0.013 
P00920 Carbonic anhydrase 2 -2.437 0.002 
Q9JII5 DAZ-associated protein 1  -2.428 0.086 
Q9JMG7 Hepatoma-derived growth factor-related protein 3  -2.241 0.025 
Q9D1M0 Protein SEC13 homolog -2.029 0.073 
P62889 60S ribosomal protein L30 -1.991 0.095 
Q62188 Dihydropyrimidinase-related protein 3  -1.981 0.009 
P48758 Carbonyl reductase [NADPH] 1 -1.963 0.005 
Q9D0F9 Phosphoglucomutase-1  -1.944 0.008 
P60335 Poly(rC)-binding protein 1  -1.918 0.024 
P62983 Ubiquitin-40S ribosomal protein S27a  -1.904 0.082 
Q9R0P5 Destrin -1.882 0.003 
P26369 Splicing factor U2AF 65 kDa subunit  -1.872 0.004 
P16546 Spectrin alpha chain, non-erythrocytic 1 -1.871 0.019 
Q64727 Vinculin -1.865 0.041 
Q7TPR4 Alpha-actinin-1 -1.859 0.013 
Q8K183 Pyridoxal kinase  -1.823 0.069 
Q61598 Rab GDP dissociation inhibitor beta  -1.778 0.011 
Q8BTM8 Filamin-A  -1.775 0.037 
Q9QXT0 Protein canopy homolog 2  -1.721 0.031 
P63254 Cysteine-rich protein 1 -1.663 0.078 
P47754 F-actin-capping protein subunit alpha-2  -1.639 0.015 
P61922 4-aminobutyrate aminotransferase, mitochondrial  -1.633 0.051 
P31230 
Aminoacyl tRNA synthase complex-interacting 
multifunctional protein 1 -1.631 0.055 
P21614 Vitamin D-binding protein  -1.625 0.055 
Q99L13 
3-hydroxyisobutyrate dehydrogenase, 
mitochondrial  -1.579 0.083 
P04104 Keratin, type II cytoskeletal 1  -1.552 0.076 
Q99JF8 PC4 and SFRS1-interacting protein  -1.541 0.026 
P26443 Glutamate dehydrogenase 1, mitochondrial  -1.541 0.004 
Q8BH97 Reticulocalbin-3 -1.539 0.067 
Q8C1B7 Septin-11 -1.525 0.004 
O35887 Calumenin  -1.522 0.017 
Q91V64 Isochorismatase domain-containing protein 1 -1.478 0.080 
Q06890 Clusterin  -1.457 0.010 
O55131 Septin-7  -1.432 0.038 
O08756 3-hydroxyacyl-CoA dehydrogenase type-2   -1.423 0.005 
Q9CPY7 Cytosol aminopeptidase  -1.421 0.023 
Q9Z2X1 Heterogeneous nuclear ribonucleoprotein F  -1.418 0.042 
Q9Z1Q5 Chloride intracellular channel protein 1 -1.417 0.002 
Q99MN9 
Propionyl-CoA carboxylase beta chain, 
mitochondrial  -1.410 0.035 
O54724 Caveolae-associated protein 1  -1.389 0.007 
Q60973 Histone-binding protein RBBP7  -1.348 0.058 
P48678 Prelamin-A/C  -1.340 0.014 
Q9QZQ8 Core histone macro-H2A.1  -1.315 0.058 
P13020 Gelsolin -1.293 0.061 
P99027 60S acidic ribosomal protein P2 -1.281 0.069 
P01027 Complement C3   -1.272 0.047 
P27659 60S ribosomal protein L3  -1.263 0.057 
P01867 Ig gamma-2B chain C region -1.263 0.0453 
Q9D2G2 
Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial  -1.251 0.023 
Q9D0J8 Parathymosin -1.249 0.051 
P99024 Tubulin beta-5 chain -1.240 0.074 
O88531 Palmitoyl-protein thioesterase 1  -1.238 0.014 
Q8BG05 Heterogeneous nuclear ribonucleoprotein A3  -1.211 0.053 
P70699 Lysosomal alpha-glucosidase  -1.206 0.021 
P24452 Macrophage-capping protein  -1.184 0.002 
P42208 Septin-2  -1.183 0.073 
P40124 Adenylyl cyclase-associated protein 1  -1.180 0.093 
Q8BIJ6 Isoleucine--tRNA ligase, mitochondrial -1.173 0.083 
P26350 Prothymosin alpha  -1.170 0.034 
Q62261 Spectrin beta chain, non-erythrocytic 1  -1.160 0.080 
P63325 40S ribosomal protein S10 -1.155 0.068 
Q6IRU2 Tropomyosin alpha-4 chain  -1.153 0.075 
P26645 Myristoylated alanine-rich C-kinase substrate  -1.147 0.029 
P08207 Protein S100-A10  -1.141 0.051 
P83917 Chromobox protein homolog 1 -1.141 0.081 
P62960 Nuclease-sensitive element-binding protein 1  -1.139 0.090 
Q9WVA3 Mitotic checkpoint protein BUB3  -1.139 0.047 
Q03265 ATP synthase subunit alpha, mitochondrial -1.136 0.057 
P55264 Adenosine kinase  -1.136 0.023 
Q61545 RNA-binding protein EWS -1.121 0.015 
Q6NVF9 
Cleavage and polyadenylation specificity factor 
subunit 6 -1.090 0.041 
P26039 Talin-1 -1.076 0.097 
P09813 Apolipoprotein A-II  -1.071 0.056 
P63168 Dynein light chain 1, cytoplasmic  -1.070 0.026 
Q9WV32 Actin-related protein 2/3 complex subunit 1B  -1.069 0.044 
P56399 Ubiquitin carboxyl-terminal hydrolase 5  -1.037 0.046 
P24270 Catalase  -1.034 0.043 
Q9WVA4 Transgelin-2 -1.015 0.052 
Q05920 Pyruvate carboxylase, mitochondrial  -1.013 0.088 
Q9QYC0 Alpha-adducin  -1.009 0.054 
Q8BFW7 Lipoma-preferred partner homolog -1.006 0.042 
P18760 Cofilin-1  -1.004 0.096 
A2BDX3 Adenylyltransferase and sulfurtransferase MOCS3  1.138 0.076 
O08795 Glucosidase 2 subunit beta  1.145 0.087 
Q64433 10 kDa heat shock protein, mitochondrial  1.209 0.078 
Q62093 Serine/arginine-rich splicing factor 2  1.905 0.008 
 17 
Supplementary Table 2: Ovarian proteins identified by LC-MS/MS to differ in offspring of dams 18 
fed a HFHS diet during gestation and a chow diet in adulthood (DHPL) relative to offspring of dams 19 
fed a chow diet during gestation and a lean diet in adulthood (DLPL) mice (log2foldchange  1 and 20 
P-value  0.1).   21 
 22 
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Supplementary Table 3 46 
 47 
UniProtID Protein names log2(FC) p value 
O88531 Palmitoyl-protein thioesterase 1 -2.159 0.006 
Q9WUK2 Eukaryotic translation initiation factor 4H -2.023 0.094 
Q9CY58 
Plasminogen activator inhibitor 1 RNA-binding 
protein -1.954 0.058 
P62830 60S ribosomal protein L23 -1.884 0.066 
Q9WV54 Acid ceramidase -1.860 0.067 
P01027 Complement C3  -1.826 0.042 
P40124 Adenylyl cyclase-associated protein 1 -1.677 0.036 
Q99L13 3-hydroxyisobutyrate dehydrogenase, mitochondrial  -1.668 0.041 
P17225 Polypyrimidine tract-binding protein 1 -1.664 0.093 
Q9QXT0 Protein canopy homolog 2  -1.647 0.053 
Q9CPU0 Lactoylglutathione lyase  -1.570 0.050 
Q61545 RNA-binding protein EWS -1.537 0.080 
P62889 60S ribosomal protein L30 -1.520 0.073 
P21614 Vitamin D-binding protein  -1.457 0.023 
P26039 Talin-1 -1.420 0.034 
P02088 Hemoglobin subunit beta-1  -1.393 0.096 
Q8C1B7 Septin-11 -1.369 0.081 
P61922 4-aminobutyrate aminotransferase, mitochondrial       -1.353 
 
0.014 
 
P26443 Glutamate dehydrogenase 1, mitochondrial  -1.340 0.018 
O08756 3-hydroxyacyl-CoA dehydrogenase type-2  -1.325 0.025 
P0C0S6 Histone H2A.Z  -1.310 0.027 
Q9CQ60 6-phosphogluconolactonase  -1.250 0.061 
P04104 Keratin, type II cytoskeletal 1 -1.248 0.045 
P09671 Superoxide dismutase [Mn], mitochondrial  -1.149 0.014 
Q62188 Dihydropyrimidinase-related protein 3  -1.142 0.043 
P83917 Chromobox protein homolog 1  -1.137 0.036 
P06745 Glucose-6-phosphate isomerase  -1.110 0.066 
P26369 Splicing factor U2AF 65 kDa subunit  -1.044 0.086 
O55131 Septin-7  -1.037 0.050 
Q9CPY7 Cytosol aminopeptidase  -1.003 0.066 
A2BDX3 Adenylyltransferase and sulfurtransferase MOCS3  1.539 0.059 
Q62093 Serine/arginine-rich splicing factor 2  1.704 0.082 
P48428 Tubulin-specific chaperone A  3.120 0.003 
 48 
 49 
Supplementary Table 3: Ovarian proteins identified by LC-MS/MS to differ in offspring of dams 50 
fed a chow diet during gestation and a HFHS diet in adulthood (DLPH) relative to offspring of dams 51 
fed a chow diet during gestation and a lean diet in adulthood (DLPL) mice (log2foldchange  1 and 52 
P-value  0.1).   53 
 54 
 55 
Supplementary Table 4 56 
 57 
UniProtID Protein names log2(FC) p value 
Q9JII5 DAZ-associated protein 1  -5.132 0.004 
P06728 Apolipoprotein A-IV  -3.736 0.007 
Q9WUK2 Eukaryotic translation initiation factor 4H  -2.794 0.002 
P29699 Alpha-2-HS-glycoprotein  -2.734 0.034 
Q9D1Q6 Endoplasmic reticulum resident protein 44  -2.558 0.009 
Q9CQE8 
RNA transcription, translation and transport factor 
protein -2.529 0.022 
P01027 Complement C3  -2.267 0.013 
Q9QXT0 Protein canopy homolog 2  -2.181 0.011 
Q62348 Translin  -2.081 0.008 
P27659 60S ribosomal protein L3  -2.056 0.020 
Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial  -2.014 0.004 
P70670 
Nascent polypeptide-associated complex subunit alpha, 
muscle-specific form  -1.915 0.026 
P51859 Hepatoma-derived growth factor  -1.776 0.018 
P21981 Protein-glutamine gamma-glutamyltransferase 2  -1.767 0.075 
P10126 Elongation factor 1-alpha 1  -1.759 0.085 
P17225 Polypyrimidine tract-binding protein 1  -1.742 0.040 
Q8CI94 Glycogen phosphorylase, brain form -1.737 0.093 
P40124 Adenylyl cyclase-associated protein 1  -1.691 0.006 
O08638 Myosin-11  -1.661 0.081 
Q8VDD5 Myosin-9  -1.639 0.090 
P61982 14-3-3 protein gamma  -1.628 0.054 
P26369 Splicing factor U2AF 65 kDa subunit  -1.616 0.004 
Q9D0K2 
Succinyl-CoA:3-ketoacid coenzyme A transferase 1, 
mitochondrial  -1.611 0.009 
P01942 Hemoglobin subunit alpha -1.606 0.045 
O35855 
Branched-chain-amino-acid aminotransferase, 
mitochondrial  -1.557 0.056 
Q64727 Vinculin  -1.533 0.027 
Q8C1B7 Septin-11 -1.512 0.010 
P01867 Ig gamma-2B chain C region -1.497 0.035 
P60335 Poly(rC)-binding protein 1  -1.471 0.046 
P62301 40S ribosomal protein S13 -1.467 0.089 
Q9WUU7 Cathepsin Z -1.454 0.035 
Q9CZ13 Cytochrome b-c1 complex subunit 1, mitochondrial  -1.454 0.074 
Q9R1P3 Proteasome subunit beta type-2  -1.434 0.016 
Q9D0F9 Phosphoglucomutase-1  -1.421 0.070 
Q99PU5 Long-chain-fatty-acid--CoA ligase ACSBG1 -1.408 0.049 
Q91V92 ATP-citrate synthase  -1.388 0.082 
O35887 Calumenin  -1.358 0.044 
P02088 Hemoglobin subunit beta-1  -1.346 0.071 
P28474 Alcohol dehydrogenase class-3  -1.346 0.026 
P31786 Acyl-CoA-binding protein  -1.340 0.019 
Q8K4Z3 NAD(P)H-hydrate epimerase  -1.325 0.048 
P62880 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) 
subunit beta-2  -1.321 0.029 
P20239 Zona pellucida sperm-binding protein 2  -1.316 0.042 
Q9R1T2 SUMO-activating enzyme subunit 1  -1.311 0.069 
O08756 3-hydroxyacyl-CoA dehydrogenase type-2  -1.301 0.017 
P06801 NADP-dependent malic enzyme  -1.299 0.062 
P05202 Aspartate aminotransferase, mitochondrial  -1.261 0.028 
O09131 Glutathione S-transferase omega-1  -1.258 0.034 
P00920 Carbonic anhydrase 2  -1.255 0.077 
Q9CQV8 14-3-3 protein beta/alpha  -1.253 0.070 
O08997 Copper transport protein ATOX1  -1.226 0.061 
Q9DB15 39S ribosomal protein L12, mitochondrial  -1.225 0.055 
Q8BH95 Enoyl-CoA hydratase, mitochondrial  -1.223 0.095 
P61922 4-aminobutyrate aminotransferase, mitochondrial  -1.223 0.013 
Q9CPU0 Lactoylglutathione lyase  -1.218 0.043 
P45591 Cofilin-2  -1.214 0.096 
Q9WVA3 Mitotic checkpoint protein BUB3  -1.211 0.027 
Q60973 Histone-binding protein RBBP7  -1.210 0.044 
P26039 Talin-1 -1.208 0.038 
P99027 60S acidic ribosomal protein P2 -1.201 0.053 
P62889 60S ribosomal protein L30 -1.189 0.081 
P99029 Peroxiredoxin-5, mitochondrial  -1.183 0.014 
Q9R1P0 Proteasome subunit alpha type-4  -1.171 0.078 
P0DP28 Calmodulin-3 -1.162 0.009 
P48678 Prelamin-A/C  -1.154 0.004 
Q04447 Creatine kinase B-type  -1.148 0.064 
P19157 Glutathione S-transferase P 1  -1.142 0.070 
Q9CQF3 
Cleavage and polyadenylation specificity factor subunit 
5  -1.141 0.057 
P26443 Glutamate dehydrogenase 1, mitochondrial  -1.138 0.046 
P47754 F-actin-capping protein subunit alpha-2  -1.134 0.099 
P50247 Adenosylhomocysteinase  -1.124 0.066 
P48758 Carbonyl reductase  -1.121 0.044 
P58774 Tropomyosin beta chain  -1.121 0.082 
Q8BFW7 Lipoma-preferred partner homolog -1.109 0.044 
Q9D7B6 Isobutyryl-CoA dehydrogenase, mitochondrial  -1.091 0.072 
P16546 Spectrin alpha chain, non-erythrocytic 1 -1.087 0.029 
Q7TPR4 Alpha-actinin-1  -1.075 0.041 
O55131 Septin-7  -1.074 0.018 
Q3THE2 Myosin regulatory light chain 12B  -1.069 0.024 
Q61545 RNA-binding protein EWS -1.064 0.019 
P57780 Alpha-actinin-4 -1.058 0.064 
P35979 60S ribosomal protein L12 -1.053 0.092 
Q99MN9 Propionyl-CoA carboxylase beta chain, mitochondrial  -1.043 0.048 
P24270 Catalase  -1.035 0.054 
P63325 40S ribosomal protein S10 -1.025 0.071 
Q9CWJ9 Bifunctional purine biosynthesis protein PURH  -1.023 0.057 
P16045 Galectin-1  -1.015 0.001 
P97315 Cysteine and glycine-rich protein 1  1.256 0.060 
A2BDX3 Adenylyltransferase and sulfurtransferase MOCS3  1.395 0.067 
Q62093 Serine/arginine-rich splicing factor 2  1.421 0.006 
P48428 Tubulin-specific chaperone A 2.336 0.045 
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Supplementary Table 4: Ovarian proteins identified by LC-MS/MS to differ in offspring of dams 60 
fed a HFHS diet during gestation and a HFHS diet in adulthood (DHPH) relative to offspring of 61 
dams fed a chow diet during gestation and a lean diet in adulthood (DLPL) mice (log2foldchange 62 
 1 and P-value  0.1).   63 
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Supplementary Table 5 79 
 80 
UniProtID Protein names log2(FC) p value 
Q99JI4 26S proteasome non-ATPase regulatory subunit 6 -2.115 0.099 
Q8VED5 Keratin, type II cytoskeletal 79 -1.613 0.066 
P09671 Superoxide dismutase [Mn], mitochondrial -1.428 0.009 
Q00612 Glucose-6-phosphate 1-dehydrogenase X  1.089 0.015 
Q8BH97 Reticulocalbin-3 1.506 0.087 
Q9R1P3 Proteasome subunit beta type-2  1.599 0.052 
Q8VI64 Protein MGARP  1.852 0.088 
Q62348 Translin 1.918 0.019 
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